BELSYNC Trademark

Trademark Overview

On Thursday, August 4, 2011, a trademark application was filed for BELSYNC with the United States Patent and Trademark Office. The USPTO has given the BELSYNC trademark a serial number of 85389142. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 16, 2015. This trademark is owned by Glaxo Group Limited. The BELSYNC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
belsync

General Information

Serial Number85389142
Word MarkBELSYNC
Filing DateThursday, August 4, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 16, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 9, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, March 16, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 16, 2015ABANDONMENT - NO USE STATEMENT FILED
Friday, July 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 24, 2014EXTENSION 5 GRANTED
Monday, July 14, 2014EXTENSION 5 FILED
Monday, July 14, 2014TEAS EXTENSION RECEIVED
Wednesday, February 19, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 18, 2014EXTENSION 4 GRANTED
Monday, January 27, 2014EXTENSION 4 FILED
Monday, January 27, 2014TEAS EXTENSION RECEIVED
Wednesday, September 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2013EXTENSION 3 GRANTED
Tuesday, July 30, 2013EXTENSION 3 FILED
Thursday, August 29, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 30, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 24, 2013EXTENSION 2 GRANTED
Monday, January 7, 2013EXTENSION 2 FILED
Thursday, January 24, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 7, 2013TEAS EXTENSION RECEIVED
Saturday, June 9, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 7, 2012EXTENSION 1 GRANTED
Thursday, June 7, 2012EXTENSION 1 FILED
Thursday, June 7, 2012TEAS EXTENSION RECEIVED
Tuesday, February 7, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 4, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 3, 2011ASSIGNED TO EXAMINER
Tuesday, August 9, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 8, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

belsync pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological